PT - JOURNAL ARTICLE AU - Levi, Hagai AU - Elkon, Ran AU - Shamir, Ron TI - The predictive capacity of polygenic risk scores for disease risk is only moderately influenced by imputation panels tailored to the target population AID - 10.1101/2023.08.29.23294769 DP - 2023 Jan 01 TA - medRxiv PG - 2023.08.29.23294769 4099 - http://medrxiv.org/content/early/2023/08/29/2023.08.29.23294769.short 4100 - http://medrxiv.org/content/early/2023/08/29/2023.08.29.23294769.full AB - Polygenic risk scores (PRS) predict individuals’ genetic risk of developing complex diseases. They summarize the effect of many genetic variants discovered in genome-wide association studies (GWASs). However, to date, large GWASs exist primarily for the European population and the quality of PRS prediction declines when applied to target sets of other ethnicities. A key step in using a PRS is imputation, which is the inference of un-typed SNPs using a set of fully-sequenced individuals, called the imputation panel. The SNP genotypes called by the imputation process depend on the ethnic composition of the imputation panel. Several studies have shown that imputing genotypes using a panel that contains individuals of the same ethnicity as the genotyped individuals improves imputation accuracy. However, until now, there has been no systematic investigation into the influence of the ethnic composition of imputation panels on the accuracy of PRS predictions when applied to ethnic groups that differ from the population used in the GWAS.In this study we estimated the effect of imputation of the target set on prediction accuracy of PRS when the discovery (GWAS) and the target sets come from different ethnic groups. We analyzed twelve binary phenotypes and three populations from the UK Biobank (Europeans, South-Asians, and Africans). We generated imputation panels from several ethnic groups, imputed the target set using each panel, and generated PRS to compute individuals’ risk scores. Then, we assessed the prediction accuracy obtained from each imputation panel. Our analysis indicates that using an imputation panel matched to the ethnic group of the target population yields only a marginal improvement and only under specific conditions. Hence, while a target-matched imputation panel can potentially improve prediction accuracy of European PRSs in non-EUR populations, the improvement is limited.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported in part by grants from the Israeli Science Foundation (No. 3165/19, within the Israel Precision Medicine Partnership program, and No. 2206/22, to RS), from the Tel Aviv University Center for AI and Data Science (TAD) to RE and RS, by a joint program grant from the Cancer Biology Research Center, Djerassi Oncology Center, Edmond J. Safra Center for Bioinformatics and TAD to RE, and by the Koret-UC Berkeley-Tel Aviv University Initiative in Computational Biology and Bioinformatics to RE and RS. HL was supported in part by a fellowship from the Edmond J. Safra Center for Bioinformatics at Tel Aviv University.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study used (or will use) ONLY openly available human data that were originally located at the UK Biobank, dbGAP, and the Human Genome Phenome ArchiveI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request by the UK Biobank and dbGAP and the Human Genome Phenome Archive.